In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition ; volume:24 ; number:1 ; day:13 ; month:1 ; year:2022 ; pages:1-17 ; date:1.2022
The AAPS journal / American Association of Pharmaceutical Scientists ; 24, Heft 1 (13.1.2022), 1-17, 1.2022
- Creator
-
Murata, Yukiko
Neuhoff, Sibylle
Rostami-Hodjegan, Amin
Takita, Hiroyuki
Al-Majdoub, Zubida M.
Ogungbenro, Kayode
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1208/s12248-021-00675-w
- URN
-
urn:nbn:de:101:1-2022052908410887342029
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Murata, Yukiko
- Neuhoff, Sibylle
- Rostami-Hodjegan, Amin
- Takita, Hiroyuki
- Al-Majdoub, Zubida M.
- Ogungbenro, Kayode
- SpringerLink (Online service)
Other Objects (12)
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Human physiologically based pharmacokinetic model for propofol
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Extrapolation of Hepatic Concentrations of Industrial Chemicals Using Pharmacokinetic Models to Predict Hepatotoxicity
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Human physiologically based pharmacokinetic model for propofol
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Extrapolation of Hepatic Concentrations of Industrial Chemicals Using Pharmacokinetic Models to Predict Hepatotoxicity
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Human physiologically based pharmacokinetic model for propofol
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Extrapolation of Hepatic Concentrations of Industrial Chemicals Using Pharmacokinetic Models to Predict Hepatotoxicity
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs